
Executive Burnout Psychedelic Therapy: What the Research Shows
Executive burnout psychedelic therapy is moving from the research margins into serious clinical conversation. A growing body of peer-reviewed evidence suggests that psilocybin-assisted therapy can reduce...

Psilocybin Alcohol Use Disorder: What Hopkins and NYU Research Found
Research on psilocybin alcohol use disorder treatment, including a landmark 2022 randomized controlled trial published in JAMA Psychiatry, has shown meaningful reductions in heavy drinking days...

Psilocybin PTSD Therapy: What the 2026 Clinical Evidence Shows
Psilocybin PTSD therapy is no longer a fringe concept. A growing body of clinical research, including Phase 2 trials published in 2025, shows that a single...

Psychedelics for Depression: What the 2026 Research Actually Shows
Quick Answer Psilocybin and other psychedelics show real, measurable promise for depression, particularly treatment-resistant cases. But the evidence in 2026 is more complicated, more honest, and...

LSD for Anxiety: What a Landmark Clinical Trial Actually Found
Quick answer: A LSD For Anxiety randomized, placebo-controlled Phase 2b trial published in JAMA found that a single oral dose of MM120, an investigational LSD formulation...

MDMA Therapy FDA Decision, What the Rejection Letter Means for Seekers
The FDA rejected Lykos Therapeutics’ application for MDMA-assisted therapy for PTSD, citing three specific concerns: gaps in safety reporting, insufficient evidence that benefits lasted over time,...

Can Psilocybin Slow Aging? A New Study Hints at What’s Possible
A peer-reviewed study in npj Aging found that psilocybin and aging may be more connected than previously assumed, after treated female mice showed reduced oxidative stress,...

Ketamine Therapy Preparation: What to Expect and Why It Matters
Ketamine therapy preparation is not a formality you complete before the real thing begins. It is a functional part of what makes the treatment work. What...

AI Digital Tripsitter: What It Can and Cannot Do for You
An AI digital tripsitter is a software tool, usually an app or chatbot, designed to support psychedelic experiences through journaling prompts, intention-setting, and guided reflection. These...

Healing Together: Psychedelic Therapy, Partnership, and the Power of Personalized Guidance
Psychedelic guide matching is one of the most important decisions a seeker can make, and at JourneyOM, it is never left to an algorithm. This post...
Ready to take the next step?
Start with a complimentary conversation, or take the two-minute self-evaluation to see if this is your moment.